Given the critical sensitivity of the data they generate, BDR Pharmaceuticals needs a highly secure and resilient infrastructure that is compliant with all regulatory agencies governing their activities such as the FDA. For backup and recovery, they had a NAS device (Synology) in place, but CTO Viral Bhavsar wanted to build out a new cloud-focused infrastructure that would support up to 25 critical systems and 3 TB of data.
With Acronis Cyber Protect deployed, BDR Pharmaceuticals saw significant improvements to financial and operational performance. On the financial side, capital expenditures (CapEx) were reduced by 30% and operational expenses (OpEx) were reduced by 12%. The operational gains were a direct result of the improved efficiencies realized from Acronis.
Read the case study to learn how Acronis Cyber Protect helped BDR Pharmaceuticals improve cyber resilience and achieve significant cost savings.